Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03072030
What this trial is testing

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Who this might be right for
Ebola Virus DiseasePrevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 2,000
Early research (Phase 1)UnknownNCT04717830
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)Study completedNCT02495246
What this trial is testing

Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Who this might be right for
Ebola Virus Disease
University of Oxford 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909358
What this trial is testing

Solidarity/Tokomeza Ebola Trial

Who this might be right for
Sudan Ebola Virus Vaccines
Makerere University 2,121
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Testing effectiveness (Phase 2)Study completedNCT05130398
What this trial is testing

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Who this might be right for
Ebola Virus Disease
Centre de Recherche Médicale de Lambaréné 120
Early research (Phase 1)Study completedNCT02718469
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Who this might be right for
Ebola Virus Disease
Auro Vaccines LLC 38
Large-scale testing (Phase 3)WithdrawnNCT05959421
What this trial is testing

Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure

Who this might be right for
Ebola Vaccine
Universitätsklinikum Hamburg-Eppendorf
Early research (Phase 1)Study completedNCT02374385
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine

Who this might be right for
Ebola Viruses
Dalhousie University 40
Not applicableNot Yet RecruitingNCT07681752
What this trial is testing

Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA

Who this might be right for
Ebola Hemorrhagic FeverLassa Hemorrhagic Fever
Institute of Tropical Medicine, Belgium 150
Large-scale testing (Phase 3)WithdrawnNCT02307591
What this trial is testing

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

Who this might be right for
Ebola Virus Disease
Emergency NGO Onlus
Early research (Phase 1)UnknownNCT02296983
What this trial is testing

Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Early research (Phase 1)Study completedNCT04906629
What this trial is testing

INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees

Who this might be right for
Ebola Virus Disease
University of Geneva, Switzerland 46
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Testing effectiveness (Phase 2)Active Not RecruitingNCT06100913
What this trial is testing

Immunology of Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Emory University 30
Testing effectiveness (Phase 2)WithdrawnNCT02271347
What this trial is testing

An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease

Who this might be right for
Ebola Virus
Jazz Pharmaceuticals
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841614
What this trial is testing

EBOla Post-Exposure Prophylaxis

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 160
Next Page